NR-AXSPA

Clinical trials for NR-AXSPA explained in plain language.

Never miss a new study

Get alerted when new NR-AXSPA trials appear

Sign up with your email to follow new studies for NR-AXSPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug shows promise for Long-Term relief in debilitating spinal arthritis

Disease control Ongoing

This study is testing the long-term safety and effectiveness of an investigational drug called bimekizumab for people with active axial spondyloarthritis, a group of painful inflammatory diseases that primarily affect the spine and joints. The trial includes 508 participants who …

Matched conditions: NR-AXSPA

Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated Mar 18, 2026 18:25 UTC

NR-AXSPA

Get alerted when new NR-AXSPA trials appear

New drug shows promise for Long-Term relief in debilitating spinal arthritis